449 related articles for article (PubMed ID: 10500117)
1. How the protease thrombin talks to cells.
Coughlin SR
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
6. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR
J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
9. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptors: the role of cell-surface proteolysis in signalling.
Cottrell GS; Coelho AM; Bunnett NW
Essays Biochem; 2002; 38():169-83. PubMed ID: 12463169
[TBL] [Abstract][Full Text] [Related]
11. Cofactoring and dimerization of proteinase-activated receptors.
Lin H; Liu AP; Smith TH; Trejo J
Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
[TBL] [Abstract][Full Text] [Related]
12. Endosomal signaling by protease-activated receptors.
Grimsey N; Lin H; Trejo J
Methods Enzymol; 2014; 535():389-401. PubMed ID: 24377935
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
Trejo J
J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
15. A dual thrombin receptor system for platelet activation.
Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
Carrim N; Arthur JF; Hamilton JR; Gardiner EE; Andrews RK; Moran N; Berndt MC; Metharom P
Redox Biol; 2015 Dec; 6():640-647. PubMed ID: 26569550
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
19. Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.
Wysoczynski M; Liu R; Kucia M; Drukala J; Ratajczak MZ
Mol Cancer Res; 2010 May; 8(5):677-90. PubMed ID: 20442298
[TBL] [Abstract][Full Text] [Related]
20. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
Altrogge LM; Monard D
Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
